drugset
drugset / Trial / NCT01826110

PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers

NCT01826110 ↗

Phase 1 Completed 21 enrolled Johns Hopkins University National Institute on Aging (NIA) · collab
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to investigate the radiotracer \[11C\] PIB in participants with probably Alzheimer's Disease (AD) and healthy age-matched controls.

Timeline

Start
2013-09
Primary completion
2018-07
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Subject 11C-PiB Diagnostic / imaging agent 555 mbq —

Indications

Alzheimer disease